Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1967 4
1968 3
1969 6
1970 5
1971 12
1972 9
1973 1
1974 5
1975 10
1976 7
1977 4
1978 8
1979 6
1980 1
1981 8
1982 4
1983 5
1984 4
1985 6
1986 6
1987 5
1988 4
1989 6
1990 3
1991 8
1992 5
1993 3
1994 8
1995 4
1996 8
1997 10
1998 9
1999 7
2000 16
2001 15
2002 10
2003 11
2004 16
2005 21
2006 16
2007 17
2008 21
2009 9
2010 18
2011 15
2012 27
2013 29
2014 23
2015 28
2016 28
2017 18
2018 28
2019 24
2020 29
2021 15
Text availability
Article attribute
Article type
Publication date

Search Results

591 results
Results by year
Filters applied: . Clear all
Page 1
Betahistine for symptoms of vertigo.
Murdin L, Hussain K, Schilder AG. Murdin L, et al. Cochrane Database Syst Rev. 2016 Jun 21;2016(6):CD010696. doi: 10.1002/14651858.CD010696.pub2. Cochrane Database Syst Rev. 2016. PMID: 27327415 Free PMC article. Review.
This review examines whether betahistine is more effective than a placebo at treating symptoms of vertigo from different causes. OBJECTIVES: To assess the effects of betahistine in patients with symptoms of vertigo from different causes. ...
This review examines whether betahistine is more effective than a placebo at treating symptoms of vertigo from different causes. OBJE …
Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial.
Scholtz AW, Hahn A, Stefflova B, Medzhidieva D, Ryazantsev SV, Paschinin A, Kunelskaya N, Schumacher K, Weisshaar G. Scholtz AW, et al. Clin Drug Investig. 2019 Nov;39(11):1045-1056. doi: 10.1007/s40261-019-00858-6. Clin Drug Investig. 2019. PMID: 31571128 Free PMC article. Clinical Trial.
The objective of the present study was to evaluate whether the fixed combination of cinnarizine and dimenhydrinate (Arlevert()) is non-inferior and thus a potentially useful alternative to betahistine dihydrochloride in the treatment of patients suffering from perip …
The objective of the present study was to evaluate whether the fixed combination of cinnarizine and dimenhydrinate (Arlevert()) is non-infer …
Use of betahistine in the treatment of peripheral vertigo.
Ramos Alcocer R, Ledezma Rodríguez JG, Navas Romero A, Cardenas Nuñez JL, Rodríguez Montoya V, Deschamps JJ, Liviac Ticse JA. Ramos Alcocer R, et al. Acta Otolaryngol. 2015;135(12):1205-11. doi: 10.3109/00016489.2015.1072873. Epub 2015 Aug 6. Acta Otolaryngol. 2015. PMID: 26245698 Review.
The review also presents an update on the mechanisms of action, pharmacodynamics, and pharmacokinetics of betahistine. RESULTS: Efficacy and safety of betahistine has been demonstrated in numerous clinical trials. The precise mechanism of action of betahistine
The review also presents an update on the mechanisms of action, pharmacodynamics, and pharmacokinetics of betahistine. RESULTS: Effic …
Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).
Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M; BEMED Study Group. Adrion C, et al. BMJ. 2016 Jan 21;352:h6816. doi: 10.1136/bmj.h6816. BMJ. 2016. PMID: 26797774 Free PMC article. Clinical Trial.
STUDY QUESTION: What is the long term efficacy of betahistine dihydrochloride on the incidence of vertigo attacks in patients with Meniere's disease, compared with placebo? ...Adults aged 21-80 years (mean age 56 years) with definite unilateral or bilateral Meniere' …
STUDY QUESTION: What is the long term efficacy of betahistine dihydrochloride on the incidence of vertigo attacks in patients …
Is betahistine effective for Menieres disease?
Rosenbaum A, Winter M. Rosenbaum A, et al. Medwave. 2017 Oct 31;17(8):e7068. doi: 10.5867/medwave.2017.08.7068. Medwave. 2017. PMID: 29099816 Review. English, Spanish.
PROBLEM: Menieres disease is an inner ear disorder characterized by episodes of spontaneous vertigo, fluctuating hearing loss and tinnitus. Betahistine has been used to reduce intensity and frecuency of vertigo attacks, but there is controversy regarding its effectiveness. …
PROBLEM: Menieres disease is an inner ear disorder characterized by episodes of spontaneous vertigo, fluctuating hearing loss and tinnitus. …
Menière's disease.
Wright T. Wright T. BMJ Clin Evid. 2015 Nov 5;2015:0505. BMJ Clin Evid. 2015. PMID: 26545070 Free PMC article. Review.
METHODS AND OUTCOMES: We conducted a systematic overview, aiming to answer the following clinical questions: What are the effects of combination treatment (betahistine plus thiazide diuretic) to prevent attacks and delay disease progression of Meniere's disease? ...CONCLUS …
METHODS AND OUTCOMES: We conducted a systematic overview, aiming to answer the following clinical questions: What are the effects of combina …
Report from a Consensus Conference on the treatment of Meniere's disease with betahistine: rationale, methodology and results.
Casani AP, Guidetti G, Schoenhuber R; Consensus Conference Group. Casani AP, et al. Acta Otorhinolaryngol Ital. 2018 Oct;38(5):460-467. doi: 10.14639/0392-100X-2035. Acta Otorhinolaryngol Ital. 2018. PMID: 30498275 Free PMC article.
The consensus conference on betahistine for Meniere's disease involved a group of Italian experts in vestibular disorders who were asked a series of questions prepared by opinion leaders. ...However, during the acute phase of the disease betahistine was considered l …
The consensus conference on betahistine for Meniere's disease involved a group of Italian experts in vestibular disorders who were as …
Betahistine dihydrochloride transdermal delivery via optimized thermosensitive gels: percutaneous absorption evaluation using rat growth as a biomarker.
Elkomy MH, El-Menshawe SF, Ali AA, Halawa AA, El-Din ASGS. Elkomy MH, et al. Drug Deliv Transl Res. 2018 Feb;8(1):165-177. doi: 10.1007/s13346-017-0449-5. Drug Deliv Transl Res. 2018. PMID: 29159693
The aim of this study was to develop and optimize a betahistine dihydrochloride (BH) thermoreversible bioadhesive gel intended for transdermal delivery. ...
The aim of this study was to develop and optimize a betahistine dihydrochloride (BH) thermoreversible bioadhesive gel intended …
International consensus (ICON) on treatment of Ménière's disease.
Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V. Nevoux J, et al. Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Feb;135(1S):S29-S32. doi: 10.1016/j.anorl.2017.12.006. Epub 2018 Jan 12. Eur Ann Otorhinolaryngol Head Neck Dis. 2018. PMID: 29338942 Free article. Review.
As a conservative medical treatment of first line, the authors recommend to use diuretics and Betahistine or local pressure therapy. When medical treatment fails, the recommendation is to use a second line treatment, which consists in the intratympanic injection of steroid …
As a conservative medical treatment of first line, the authors recommend to use diuretics and Betahistine or local pressure therapy. …
591 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page